Global clinical trial solutions provider ClinEdge has enhanced its ‘Community Clinical Study Services’ product line, a community-based solution that streamlines the clinical trial process and connects participating sites.

The remote, patient-centric solution virtually connects participating sites, labs, and patients.

ClinEdge has partnered with both research sites and pharmaceutical firms to conduct clinical trials, manage patient recruitment, and to construct and execute patient engagement strategies.

According to the company, the Community Clinical Study Service model plugs into ongoing or upcoming studies with home health care integration, which includes at-home visit completion, staffing, handling, as well as courier services.

The remote visit assessments of the patients are telemedicine-enabled, allowing the seamless tracking of patient source. These assessments adhere with FDA guidelines and stay at home guidelines.

ClinEdge co-founder Christian Burns said: “The Covid-19 pandemic has increased the demand of our trial support services, mainly our ability to deploy and manage global Home Care visits, IP and lab logistics, remote care via telehealth, and enabling remote based monitoring through Esource technology.”

Until now, ClinEdge has been engaged in providing services to both site and pharmaceutical partners, using the same central service offering that enhances study management of pharmaceutical companies and CROs.

ClinEdge, via a central point of contact, ensures that the component meets the required regulatory guidelines required for superior patient care.

ClinEdge co-founder Al Peters added: “We are uniquely positioned to help contribute to change. Our company’s purpose and mission has always been to improve the site and patient clinical study journey and by executing on this new category of trial support, we will help evolve the paradigm of the current trial workflow and allow for recurring processes to be realised.”